Información del producto
Nombre:FDI-6
Marca:Biosynth
Descripción:FDI-6 is a novel anti-cancer prodrug that is activated by the enzyme cytochrome p450. It has been shown to induce apoptotic cell death in hematopoietic cells and cancer cells, as well as inhibit the growth of hepatocellular carcinoma (HCC) cells. FDI-6 induces apoptotic cell death in hematopoietic cells by stimulating the mitochondrial pathway of apoptosis and inhibiting mitochondrial membrane permeability. FDI-6 also inhibits HCC cells by inducing apoptosis and increasing the levels of reactive oxygen species (ROS) in these cancerous cells.FDI-6 has been shown to be effective against chemotherapy resistant cancer cells due to its ability to induce DNA damage. FDI-6 also has a beneficial effect on biochemical markers of metabolic disorders such as hypertriglyceridemia and hypercholesterolemia, suggesting that it may have therapeutic potential for treating these diseases.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:437.43 g/mol
Fórmula:C19H11F4N3OS2
Pureza:Min. 95%
Consulta técnica sobre: FDI-6
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.